CATHERINE BORCHERT: Open Payments
NPI 1992918692 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 29 payments from 4 companies in 2025. Trend: 2023 $346 · 2024 $598 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $233 |
| Otsuka America Pharmaceutical, Inc. | 8 | $218 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
Products named: VRAYLAR, REXULTI, Auvelity, FANAPT.
Industry payments across CA — which companies pay providers there.
